Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsThe tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.
Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.
1.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
2.
Young adults who are obese are at risk for 17 different types of cancer in the future.
3.
A study has developed molecular markers that predict meningioma recurrence.
4.
Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women
5.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
1.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
2.
Advanced Methods in Oncology in Daily Practice
3.
Understanding the Rare Disease: Werner Syndrome Explained
4.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
5.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge